1. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification;Vallespi, T.; Torrabadella, A.; Julia, D.;Br J Haematol; coprotein seen in myelodysplasia are similar in morphology to the micromegakaryocytes we have previously detected (also by means of the APAAP staining technique) in the circulation of some cases of,1985
2. Proposals for the classification of the myelodysplastic syndromes;Bennett, J.M.; Catovsky, D.; Daniel, M.T.;Br J Haematol,1982
3. Detection of cells of megakaryocyte lineage in acute myeloblastic leukaemia4 and other myeloproliferative disorders (such as chronic granulocytic leukaemia and essential thrombocythemia; unpublished observations). The present study sheds haematologic malignancies by immuno-alkaline phosphatase labelling cell smears with a panel of monoclonal antibodies;Erber, W.N.; Breton-Gorius, J.; Villeval, J.L.; Oscier, D.G.; Bai, Y.; Mason, D.Y.;Br J Haematol,1987
4. Von Dem Borne AEG. Monoclonal antibodies against human platelet glylight on the origin of the circulating micromegakaryocytes seen in patients with myelodysplasia as immunocytochemical labelling of bone marrow smears revealed, in addition to the previously coprotein II1a;Tetteroo, P.A.T.; Lansdorp, P.M.; Leeksma, O.C.;Br J Haematol,1983
5. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes;Cordell, J.L.; Falini, B.; Erber, W.N.;J Histochem Cytochem,1984